BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 2702251)

  • 1. Theory and practice in the individualization of oral pancreatic enzyme administration for chronic pancreatitis.
    Andrén-Sandberg A
    Int J Pancreatol; 1989; 5 Suppl():51-62. PubMed ID: 2702251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Management of chronic pancreatitis. Focus on enzyme replacement therapy.
    Dobrilla G
    Int J Pancreatol; 1989; 5 Suppl():17-29. PubMed ID: 2702247
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical and pharmacological aspects of pancreatic enzyme substitution therapy].
    Löser C; Fölsch UR
    Leber Magen Darm; 1991 Mar; 21(2):56, 59-62, 65. PubMed ID: 1710011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency.
    Regan PT; Malagelada JR; DiMagno EP; Glanzman SL; Go VL
    N Engl J Med; 1977 Oct; 297(16):854-8. PubMed ID: 20572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Differential therapy of exocrine pancreatic insufficiency--current aspects and future prospects of substitution therapy with pancreatic enzymes].
    Löser C; Fölsch UR
    Z Gastroenterol; 1995 Dec; 33(12):715-22. PubMed ID: 8585255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic enzyme pharmacotherapy.
    Ferrone M; Raimondo M; Scolapio JS
    Pharmacotherapy; 2007 Jun; 27(6):910-20. PubMed ID: 17542772
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic enzyme replacement therapy: comparative effects of conventional and enteric-coated microspheric pancreatin and acid-stable fungal enzyme preparations on steatorrhoea in chronic pancreatitis.
    Schneider MU; Knoll-Ruzicka ML; Domschke S; Heptner G; Domschke W
    Hepatogastroenterology; 1985 Apr; 32(2):97-102. PubMed ID: 2408983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Does enzyme substitution therapy reduce pain in chronic pancreatitis?].
    Hansen ML; Rumessen JJ
    Ugeskr Laeger; 2005 Apr; 167(17):1841-4. PubMed ID: 15929329
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatic enzymes replacement therapy in chronic pancreatitis: an update.
    Trifan A; Balan G; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2001; 105(4):646-50. PubMed ID: 12092213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quality of life in the course of enzyme replacement therapy for chronic pancreatitis].
    Czakó L; Takács T; Lonovics J; Lakner L; Döbrönte Z; Prónai L; Tulassay Z
    Orv Hetil; 2002 Jun; 143(25):1521-7. PubMed ID: 12577405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of pancreatic enzyme microsphere technology and US findings with Pancrease in the treatment of chronic pancreatitis.
    DeYoung JL
    Int J Pancreatol; 1989; 5 Suppl():31-6. PubMed ID: 2702248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of maldigestion associated with pancreatic insufficiency.
    Perry RS; Gallagher J
    Clin Pharm; 1985; 4(2):161-9. PubMed ID: 3987214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of the therapeutic efficacy of a pH-sensitive enteric coated pancreatic enzyme preparation with conventional pancreatic enzyme therapy in the treatment of exocrine pancreatic insufficiency.
    Dutta SK; Rubin J; Harvey J
    Gastroenterology; 1983 Mar; 84(3):476-82. PubMed ID: 6549746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage?
    Lankisch PG; Lembcke B; Göke B; Creutzfeldt W
    Z Gastroenterol; 1986 Dec; 24(12):753-7. PubMed ID: 3548109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral pancreatic enzyme substitution therapy in chronic pancreatitis: is clinical response an appropriate marker for evaluation of therapeutic efficacy?
    Domínguez-Muñoz JE; Iglesias-García J
    JOP; 2010 Mar; 11(2):158-62. PubMed ID: 20208327
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy with pancreatic enzyme preparations].
    Holtmann G; Layer P
    Med Monatsschr Pharm; 1993 Feb; 16(2):38-42. PubMed ID: 8441359
    [No Abstract]   [Full Text] [Related]  

  • 18. [Efficacy of a new microencapsulated pancreatin versus a conventional preparation, in the treatment of steatorrhea of pancreatic origin].
    Aparisi L; Rodrigo JM; Serra MA; Del Olmo J; Bisquert M; Raga F
    Rev Esp Enferm Apar Dig; 1989 Jul; 76(1):25-30. PubMed ID: 2799034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fate of orally ingested enzymes in pancreatic insufficiency. Comparison of two dosage schedules.
    DiMagno EP; Malagelada JR; Go VL; Moertel CG
    N Engl J Med; 1977 Jun; 296(23):1318-22. PubMed ID: 16213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pancreatic enzyme replacement therapy. Importance of gastric acid secretion, H2-antagonists, and enteric coating.
    Marotta F; O'Keefe SJ; Marks IN; Girdwood A; Young G
    Dig Dis Sci; 1989 Mar; 34(3):456-61. PubMed ID: 2563963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.